Ampliphi Biosciences Corp (APHB) Sees Large Decrease in Short Interest
Ampliphi Biosciences Corp (NYSE:APHB) saw a large drop in short interest in the month of September. As of September 29th, there was short interest totalling 825,381 shares, a drop of 13.1% from the September 15th total of 950,278 shares. Based on an average daily trading volume, of 249,608 shares, the short-interest ratio is currently 3.3 days. Approximately 9.6% of the company’s shares are sold short.
Ampliphi Biosciences Corp (NYSE APHB) opened at 1.0825 on Wednesday. The stock has a 50 day moving average price of $0.85 and a 200 day moving average price of $1.08. Ampliphi Biosciences Corp has a 52-week low of $0.67 and a 52-week high of $15.40. The company’s market capitalization is $9.47 million.
TRADEMARK VIOLATION NOTICE: “Ampliphi Biosciences Corp (APHB) Sees Large Decrease in Short Interest” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.americanbankingnews.com/2017/10/11/ampliphi-biosciences-corp-aphb-sees-large-decrease-in-short-interest.html.
Ampliphi Biosciences Corp Company Profile
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.
Receive News & Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related companies with MarketBeat.com's FREE daily email newsletter.